{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:51:20Z","timestamp":1793317880464,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Distinguishable sex differences exist in fat mass and muscle mass. High fat mass and low muscle mass are independently associated with cardiovascular disease (CVD) risk factors in people living with type 2 diabetes; however, it is unknown if the association between fat mass and CVD risk is modified by muscle mass, or vice versa. This study examined the sex-specific interplay between fat mass and muscle mass on CVD risk factors in adults with type 2 diabetes\u00a0living with overweight and obesity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Dual-energy X-ray absorptiometry (DXA) measures were used to compute fat mass index (FMI) and appendicular muscle mass index (ASMI), and participants were separated into high-fat mass vs. low-fat mass and high-muscle mass vs. low-muscle mass. A two-way analysis of covariance (ANCOVA: high-FMI vs. low-FMI by high-ASMI vs. low-ASMI) was performed on CVD risk factors (i.e., hemoglobin A1C [A1C]; high-density lipoprotein cholesterol; low-density lipoprotein cholesterol; triglycerides; systolic and diastolic blood pressure; cardiorespiratory fitness, depression and health related-quality of life [HR-QoL]) at baseline and following a 1-year intensive lifestyle intervention (ILI) for females and males separately, with a primary focus on the fat mass by muscle mass interaction effects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Data from 1,369 participants (62.7% females) who completed baseline DXA were analyzed. In females, there was a fat mass by muscle mass interaction effect on A1C (p\u2009=\u20090.016) at baseline. Post-hoc analysis showed that, in the low-FMI group, A1C was significantly higher in low-ASMI when compared to high-ASMI (60.3\u2009\u00b1\u200914.1 vs. 55.5\u2009\u00b1\u200913.5\u00a0mmol\/mol, p\u2009=\u20090.023). In the high-FMI group, there was no difference between high-ASMI and low-ASMI (56.4\u2009\u00b1\u200912.5 vs. 56.5\u2009\u00b1\u200912.8\u00a0mmol\/mol, p\u2009=\u20090.610). In males, only high-FMI was associated with higher A1C when compared to low-FMI (57.1\u2009\u00b1\u200914.4 vs. 54.2\u2009\u00b1\u200912.0\u00a0mmol\/mol, p\u2009=\u20090.008) at baseline. Following ILI, there were significant fat mass by muscle mass interaction effects on changes in the mental component of HR-QoL in males.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Considering that A1C predicts future CVD, strategies to lower A1C may be especially important in females with low fat and low muscle mass living with type 2 diabetes. Our results highlight the complicated and sex-specific contribution of fat mass and muscle mass to CVD risk factors.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-022-01468-x","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T16:10:52Z","timestamp":1647360652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Sex-specific associations of fat mass and muscle mass with cardiovascular disease risk factors in adults with type 2 diabetes living with overweight and obesity: secondary analysis of the Look AHEAD trial"],"prefix":"10.1186","volume":"21","author":[{"given":"Tasuku","family":"Terada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol","family":"Vidal-Almela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus","family":"Mistura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley L.","family":"Way","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"key":"1468_CR1","unstructured":"Hales CM CM, Cheryl D, Fryar CD, Ogden CL. Revalence of obesity and severe obesity among adults: United States, 2017\u20132018. NCHS Data Brief, No 360. Hyattsville, MD: National Center for Health Statistics. 2020."},{"key":"1468_CR2","doi-asserted-by":"crossref","unstructured":"Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 2014; 43(6):748\u2013759.","DOI":"10.1093\/ageing\/afu115"},{"issue":"10","key":"1468_CR3","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/gerona\/glx002","volume":"72","author":"JA Batsis","year":"2017","unstructured":"Batsis JA, Mackenzie TA, Emeny RT, Lopez-Jimenez F, Bartels SJ. Low lean mass with and without obesity, and mortality: results from the 1999\u20132004 National Health and Nutrition Examination Survey. J Gerontol A Biol Sci Med Sci. 2017;72(10):1445\u201351.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1468_CR4","unstructured":"Center for Disease Control and Prevention. National Diabetes Statistics Report 2020 (2020) Atlanta, GA, U.S. Dept of Health and Human Services; 2020. https:\/\/www.cdc.gov\/diabetes\/library\/features\/diabetes-stat-report.html. Accessed 20 May 2021"},{"issue":"1","key":"1468_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1079\/NRR19930010","volume":"6","author":"JP Despres","year":"1993","unstructured":"Despres JP, Lamarche B. Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. Nutr Res Rev. 1993;6(1):137\u201359.","journal-title":"Nutr Res Rev"},{"issue":"1","key":"1468_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/0026-0495(87)90063-1","volume":"36","author":"S Fujioka","year":"1987","unstructured":"Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism. 1987;36(1):54\u20139.","journal-title":"Metabolism"},{"issue":"11","key":"1468_CR7","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/0026-0495(92)90016-4","volume":"41","author":"P Marin","year":"1992","unstructured":"Marin P, Andersson B, Ottosson M, et al. The morphology and metabolism of intraabdominal adipose tissue in men. Metabolism. 1992;41(11):1242\u20138.","journal-title":"Metabolism"},{"issue":"14","key":"1468_CR8","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1001\/archinte.167.14.1518","volume":"167","author":"BJ Arsenault","year":"2007","unstructured":"Arsenault BJ, Lachance D, Lemieux I, et al. Visceral adipose tissue accumulation, cardiorespiratory fitness, and features of the metabolic syndrome. Arch Intern Med. 2007;167(14):1518\u201325.","journal-title":"Arch Intern Med"},{"issue":"5","key":"1468_CR9","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1381\/096089204323093336","volume":"14","author":"GC van Hout","year":"2004","unstructured":"van Hout GC, van Oudheusden I, van Heck GL. Psychological profile of the morbidly obese. Obes Surg. 2004;14(5):579\u201388.","journal-title":"Obes Surg"},{"issue":"1","key":"1468_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13293-018-0189-3","volume":"9","author":"M Schorr","year":"2018","unstructured":"Schorr M, Dichtel LE, Gerweck AV, et al. Sex differences in body composition and association with cardiometabolic risk. Biol Sex Differ. 2018;9(1):28.","journal-title":"Biol Sex Differ"},{"issue":"11","key":"1468_CR11","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.2337\/dc09-0264","volume":"32","author":"SW Park","year":"2009","unstructured":"Park SW, Goodpaster BH, Lee JS, et al. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care. 2009;32(11):1993\u20137.","journal-title":"Diabetes Care"},{"issue":"5","key":"1468_CR12","doi-asserted-by":"publisher","first-page":"e10805","DOI":"10.1371\/journal.pone.0010805","volume":"5","author":"P Srikanthan","year":"2010","unstructured":"Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS ONE. 2010;5(5):e10805.","journal-title":"PLoS ONE"},{"issue":"4","key":"1468_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00223-015-9990-8","volume":"97","author":"K Tanaka","year":"2015","unstructured":"Tanaka K, Kanazawa I, Sugimoto T. Reduction in endogenous insulin secretion is a risk factor of sarcopenia in men with type 2 diabetes mellitus. Calcif Tissue Int. 2015;97(4):385\u201390.","journal-title":"Calcif Tissue Int"},{"key":"1468_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0070-2153(05)68005-2","volume":"68","author":"H Karakelides","year":"2005","unstructured":"Karakelides H, Nair KS. Sarcopenia of aging and its metabolic impact. Curr Top Dev Biol. 2005;68:123\u201348.","journal-title":"Curr Top Dev Biol"},{"issue":"6","key":"1468_CR15","doi-asserted-by":"publisher","first-page":"e100118","DOI":"10.1371\/journal.pone.0100118","volume":"9","author":"TN Kim","year":"2014","unstructured":"Kim TN, Park MS, Kim YJ, et al. Association of low muscle mass and combined low muscle mass and visceral obesity with low cardiorespiratory fitness. PLoS ONE. 2014;9(6):e100118.","journal-title":"PLoS ONE"},{"issue":"3","key":"1468_CR16","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s11845-018-01957-7","volume":"188","author":"H Olgun Yazar","year":"2019","unstructured":"Olgun Yazar H, Yazar T. Prevalence of sarcopenia in patients with geriatric depression diagnosis. Ir J Med Sci. 2019;188(3):931\u20138.","journal-title":"Ir J Med Sci"},{"key":"1468_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.exger.2015.05.003","volume":"69","author":"C Beaudart","year":"2015","unstructured":"Beaudart C, Reginster JY, Petermans J, et al. Quality of life and physical components linked to sarcopenia: the SarcoPhAge study. Exp Gerontol. 2015;69:103\u201310.","journal-title":"Exp Gerontol"},{"issue":"1","key":"1468_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/jech-2019-212268","volume":"74","author":"S Tyrovolas","year":"2020","unstructured":"Tyrovolas S, Panagiotakos D, Georgousopoulou E, et al. Skeletal muscle mass in relation to 10 year cardiovascular disease incidence among middle aged and older adults: the ATTICA study. J Epidemiol Community Health. 2020;74(1):26\u201331.","journal-title":"J Epidemiol Community Health"},{"issue":"10","key":"1468_CR19","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1161\/01.CIR.100.10.1134","volume":"100","author":"SM Grundy","year":"1999","unstructured":"Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100(10):1134\u201346.","journal-title":"Circulation"},{"issue":"7","key":"1468_CR20","doi-asserted-by":"publisher","first-page":"962","DOI":"10.2337\/diacare.23.7.962","volume":"23","author":"WL Lee","year":"2000","unstructured":"Lee WL, Cheung AM, Cape D, Zinman B. Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care. 2000;23(7):962\u20138.","journal-title":"Diabetes Care"},{"issue":"1","key":"1468_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12933-018-0700-5","volume":"17","author":"T Fukuda","year":"2018","unstructured":"Fukuda T, Bouchi R, Takeuchi T, et al. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study. Cardiovasc Diabetol. 2018;17(1):55.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1468_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1152\/jappl.2000.89.1.81","volume":"89","author":"I Janssen","year":"2000","unstructured":"Janssen I, Heymsfield SB, Wang ZM, Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18\u201388 yr. J Appl Physiol. 2000;89(1):81\u20138.","journal-title":"J Appl Physiol"},{"issue":"5","key":"1468_CR23","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3390\/nu10050605","volume":"10","author":"I Trouwborst","year":"2018","unstructured":"Trouwborst I, Verreijen A, Memelink R, et al. Exercise and nutrition strategies to counteract sarcopenic cbesity. Nutrients. 2018;10(5):605.","journal-title":"Nutrients"},{"issue":"5","key":"1468_CR24","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/oby.21808","volume":"25","author":"T Terada","year":"2017","unstructured":"Terada T, Boul\u00e9 NG, Forhan M, et al. Cardiometabolic risk factors in type 2 diabetes with high fat and low muscle mass: at baseline and in response to exercise. Obesity. 2017;25(5):881\u201391.","journal-title":"Obesity"},{"issue":"2","key":"1468_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJMoa1212914","volume":"369","author":"RR Wing","year":"2013","unstructured":"Wing RR, Bolin P, Brancati FL, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145\u201354.","journal-title":"N Engl J Med"},{"issue":"12","key":"1468_CR26","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","volume":"12","author":"E von Elm","year":"2014","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495\u20139.","journal-title":"Int J Surg"},{"issue":"17","key":"1468_CR27","first-page":"1566","volume":"170","author":"Look AHEAD Research Group","year":"2010","unstructured":"Look AHEAD Research Group. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010;170(17):1566\u201375.","journal-title":"Arch Intern Med"},{"issue":"5","key":"1468_CR28","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/oby.2006.84","volume":"14","author":"TA Wadden","year":"2006","unstructured":"Wadden TA, West DS, Delahanty L, et al. The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity. 2006;14(5):737\u201352.","journal-title":"Obesity"},{"issue":"9","key":"1468_CR29","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/ijo.2010.268","volume":"35","author":"JE Galgani","year":"2011","unstructured":"Galgani JE, Smith SR, Ravussin E. Assessment of EchoMRI-AH versus dual-energy X-ray absorptiometry to measure human body composition. Int J Obes. 2011;35(9):1241\u20136.","journal-title":"Int J Obes"},{"issue":"1","key":"1468_CR30","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.clnu.2018.01.022","volume":"38","author":"C Van Aller","year":"2019","unstructured":"Van Aller C, Lara J, Stephan BCM, et al. Sarcopenic obesity and overall mortality: Results from the application of novel models of body composition phenotypes to the National Health and Nutrition Examination Survey 1999\u20132004. Clin Nutr. 2019;38(1):264\u201370.","journal-title":"Clin Nutr"},{"issue":"5","key":"1468_CR31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/gerona\/glu010","volume":"69","author":"SA Studenski","year":"2014","unstructured":"Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547\u201358.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1468_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.metabol.2019.01.004","volume":"94","author":"T Terada","year":"2019","unstructured":"Terada T, Boul\u00e9 NG. Does metformin therapy influence the effects of intensive lifestyle intervention? Exploring the interaction between first line therapies in the Look AHEAD trial. Metabolism. 2019;94:39\u201346.","journal-title":"Metabolism"},{"issue":"6","key":"1468_CR33","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.2337\/dc13-1928","volume":"37","author":"RR Rubin","year":"2014","unstructured":"Rubin RR, Wadden TA, Bahnson JL, et al. Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial. Diabetes Care. 2014;37(6):1544\u201353.","journal-title":"Diabetes Care"},{"key":"1468_CR34","first-page":"4","volume":"28","author":"GF Templeton","year":"2011","unstructured":"Templeton GF. A two-step approach for transforming continuous variables to normal: implications and recommendations for IS research. Commun Assoc Inf Systems. 2011;28:4.","journal-title":"Commun Assoc Inf Systems"},{"issue":"6","key":"1468_CR35","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.diabet.2019.02.007","volume":"45","author":"CC Lin","year":"2019","unstructured":"Lin CC, Li CI, Liu CS, et al. Obesity paradox in associations between body mass index and diabetes-related hospitalization and mortality in patients with type 2 diabetes: retrospective cohort studies. Diabetes Metab. 2019;45(6):564\u201372.","journal-title":"Diabetes Metab"},{"issue":"4","key":"1468_CR36","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2337\/dc12-0944","volume":"36","author":"J Logue","year":"2013","unstructured":"Logue J, Walker JJ, Leese G, et al. Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality. Diabetes Care. 2013;36(4):887\u201393.","journal-title":"Diabetes Care"},{"issue":"2","key":"1468_CR37","doi-asserted-by":"publisher","first-page":"e000077","DOI":"10.1161\/JAHA.112.000077","volume":"2","author":"JK Pai","year":"2013","unstructured":"Pai JK, Cahill LE, Hu FB, Rexrode KM, Manson JE, Rimm EB. Hemoglobin a1c is associated with increased risk of incident coronary heart disease among apparently healthy, nondiabetic men and women. J Am Heart Assoc. 2013;2(2):e000077.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"1468_CR38","doi-asserted-by":"publisher","first-page":"e0123116","DOI":"10.1371\/journal.pone.0123116","volume":"10","author":"YY Chen","year":"2015","unstructured":"Chen YY, Lin YJ, Chong E, et al. The impact of diabetes mellitus and corresponding HbA1c levels on the future risks of cardiovascular disease and mortality: a representative cohort study in Taiwan. PLoS ONE. 2015;10(4):e0123116.","journal-title":"PLoS ONE"},{"issue":"12 Pt 2","key":"1468_CR39","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.1301\/nr.2007.dec.S208-S212","volume":"65","author":"R Roubenoff","year":"2007","unstructured":"Roubenoff R. Physical activity, inflammation, and muscle loss. Nut Rev. 2007;65(12 Pt 2):S208-212.","journal-title":"Nut Rev"},{"issue":"10","key":"1468_CR40","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S2213-8587(14)70034-8","volume":"2","author":"RR Kalyani","year":"2014","unstructured":"Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2014;2(10):819\u201329.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"1468_CR41","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1089\/met.2017.0128","volume":"16","author":"R de Mutsert","year":"2018","unstructured":"de Mutsert R, Gast K, Widya R, et al. Associations of abdominal subcutaneous and visceral fat with insulin resistance and secretion differ between men and women: The Netherlands epidemiology of obesity study. Metab Syndr Relat Disord. 2018;16(1):54\u201363.","journal-title":"Metab Syndr Relat Disord"},{"key":"1468_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.atherosclerosis.2020.04.019","volume":"304","author":"DJ Chu","year":"2020","unstructured":"Chu DJ, Al Rifai M, Virani SS, Brawner CA, Nasir K, Al-Mallah MH. The relationship between cardiorespiratory fitness, cardiovascular risk factors and atherosclerosis. Atherosclerosis. 2020;304:44\u201352.","journal-title":"Atherosclerosis"},{"issue":"11","key":"1468_CR43","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMoa011858","volume":"346","author":"J Myers","year":"2002","unstructured":"Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793\u2013801.","journal-title":"N Engl J Med"},{"issue":"3","key":"1468_CR44","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3390\/jpm11030176","volume":"11","author":"O Patsalos","year":"2021","unstructured":"Patsalos O, Keeler J, Schmidt U, Penninx B, Young AH, Himmerich H. Diet, obesity, and depression: a systematic review. J Pers Med. 2021;11(3):176.","journal-title":"J Pers Med"},{"issue":"6","key":"1468_CR45","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/cob.12208","volume":"7","author":"NR Fuller","year":"2017","unstructured":"Fuller NR, Burns J, Sainsbury A, et al. Examining the association between depression and obesity during a weight management programme. Clin Obes. 2017;7(6):354\u20139.","journal-title":"Clin Obes"},{"issue":"3","key":"1468_CR46","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/oby.21005","volume":"23","author":"HJ Pownall","year":"2015","unstructured":"Pownall HJ, Bray GA, Wagenknecht LE, et al. Changes in body composition over 8 years in a randomized trial of a lifestyle intervention: the look AHEAD study. Obesity. 2015;23(3):565\u201372.","journal-title":"Obesity"},{"issue":"2","key":"1468_CR47","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/ajcn\/76.2.473","volume":"76","author":"VA Hughes","year":"2002","unstructured":"Hughes VA, Frontera WR, Roubenoff R, Evans WJ, Singh MA. Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. Am J Clin Nutr. 2002;76(2):473\u201381.","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"1468_CR48","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412\u201323.","journal-title":"Age Ageing"},{"key":"1468_CR49","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3389\/fendo.2020.00332","volume":"11","author":"E Roh","year":"2020","unstructured":"Roh E, Choi KM. Health consequences of sarcopenic obesity: a narrative review. Front Endocrinol. 2020;11:332.","journal-title":"Front Endocrinol"},{"issue":"11","key":"1468_CR50","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1046\/j.1532-5415.2003.51534.x","volume":"51","author":"AB Newman","year":"2003","unstructured":"Newman AB, Kupelian V, Visser M, et al. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriat Soc. 2003;51(11):1602\u20139.","journal-title":"J Am Geriat Soc"},{"issue":"1","key":"1468_CR51","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/ehf2.12545","volume":"7","author":"G Fonseca","year":"2020","unstructured":"Fonseca G, Dos Santos MR, de Souza FR, et al. Discriminating sarcopenia in overweight\/obese male patients with heart failure: the influence of body mass index. ESC Heart Failure. 2020;7(1):84\u201391.","journal-title":"ESC Heart Failure"},{"issue":"1","key":"1468_CR52","doi-asserted-by":"publisher","first-page":"6491","DOI":"10.1038\/s41598-017-06831-7","volume":"7","author":"TN Kim","year":"2017","unstructured":"Kim TN, Park MS, Lee EJ, Chung HS, Yoo HJ, Kang HJ, Song W, Baik SH, Choi KM. Comparisons of three different methods for defining sarcopenia: an aspect of cardiometabolic risk. Sci Rep. 2017;7(1):6491.","journal-title":"Sci Rep"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01468-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-022-01468-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01468-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T05:06:33Z","timestamp":1666501593000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-022-01468-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,15]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1468"],"URL":"https:\/\/doi.org\/10.1186\/s12933-022-01468-x","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,15]]},"assertion":[{"value":"28 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ottawa Health Science Network Research Ethics Board (Protocol #: 20200690-01H).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}